Stockreport

PRISM MarketView Highlights Soligenix, Inc. as it Builds on Compelling Phase 3 Data with Key Catalysts on the Horizon [Yahoo! Finance]

Soligenix, Inc.  (SNGX) 
NASDAQ:AMEX Investor Relations: soligenix.com/investors
PDF Christopher Schaber, President and Chief Executive Officer of Soligenix, Inc. (Nasdaq: SNGX) . The late-stage biopharmaceutical company is advancing a broad pipeline of [Read more]